Baker Ellis Asset Management »

Contineum Therapeutics shares owned by Baker Ellis Asset Management

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Baker Ellis Asset Management from 13F filings

Historical chart of Baker Ellis Asset Management investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Baker Ellis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Baker Ellis Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $229k 20k 11.75

More positions owned by Baker Ellis Asset Management

Vanguard Index Fds Total Stk Mkt (VTI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Vanguard World Inf Tech Etf (VGT)
Vanguard Whitehall Fds High Div Yld (VYM)
Sterling Construction Company (STRL)
Dimensional Etf Trust Intl Small Cap V (DISV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
JPMorgan Chase & Co. (JPM)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Lam Research Corp Com New (LRCX)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Broadcom (AVGO)
Ishares Tr Core Msci Total (IXUS)

View all positions for Baker Ellis Asset Management

Top funds holding Contineum Therapeutics

RA Capital Management
Johnson & Johnson
Suvretta Capital Management
Franklin Resources
Vanguard Group
Balyasny Asset Management
FMR
Sectoral Asset Management
Perceptive Advisors
Hillhouse Capital Advisors
Millennium Management
Red Tree Management
Samsara BioCapital
Versant Venture Management
Point72 Asset Management

View all funds holding Contineum Therapeutics